Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: A pilot study

Journal of Psychiatric Research

Volumn 42, Issue 6, 2008, Pages 451-457

  Wang, Po W ^a   Yang, Yen shou ^a   Chandler, Rebecca A ^a   Nowakowska, Cecylia ^a   Alarcon, Andrea M ^a   Culver, Jenifer ^a   Ketter, Terence A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Depression; Obesity; Treatment; Weight loss; Zonisamide

Indexed keywords

ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CARBAMAZEPINE; HYPNOTIC SEDATIVE AGENT; LAMOTRIGINE; LITHIUM; OLANZAPINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM; ZONISAMIDE;

ADD ON THERAPY; ARTICLE; BIPOLAR DISORDER; BODY MASS; CLINICAL ARTICLE; COGNITIVE DEFECT; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; HUMAN; MALE; MANIA; NAUSEA; OBESITY; OUTPATIENT CARE; PARESTHESIA; PRESCRIPTION; PRIORITY JOURNAL; RASH; RATING SCALE; TREATMENT DURATION;

EID: 39049119838     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2007.05.005     Document Type: Article

References (37)

1. Anand A., Bukhari L., Jennings S.A., Lee C., Kamat M., Shekhar A., et al. A preliminary open-label study of zonisamide treatment for bipolar depression in 10 patients. Journal of Clinical Psychiatry 66 (2005) 195-198
2. Baldassano C.F., Ghaemi S.N., Chang A., Lyman A., and Lipari M. Acute treatment of bipolar depression with adjunctive zonisamide: a retrospective chart review. Bipolar Disorders 6 (2004) 432-434
3. Burnett W. The epidemiology of gall stones. Tijdschr Gastroenterol 14 (1971) 79-89
4. Charles C.L., Stoesz L., and Tollefson G. Zonisamide-induced mania. Psychosomatics 31 (1990) 214-217
5. Colditz G.A., Willett W.C., Stampfer M.J., Manson J.E., Hennekens C.H., Arky R.A., et al. Weight as a risk factor for clinical diabetes in women. American Journal of Epidemiology 132 (1990) 501-513
6. Denke M.A., Sempos C.T., and Grundy S.M. Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men. Archives of Internal Medicine 153 (1993) 1093-1103
7. Fagiolini A., Kupfer D.J., Houck P.R., Novick D.M., and Frank E. Obesity as a correlate of outcome in patients with bipolar I disorder. American Journal of Psychiatry 160 (2003) 112-117
8. Friedman G.D., Kannel W.B., and Dawber T.R. The epidemiology of gallbladder disease: observations in the Framingham study. Journal of Chronic Diseases 19 (1966) 273-292
9. Gadde K.M., Franciscy D.M., Wagner II H.R., and Krishnan K.R. Zonisamide for weight loss in obese adults: a randomized controlled trial. JAMA 289 (2003) 1820-1825
10. Garfinkel L. Overweight and cancer. Annals of Internal Medicine 103 (1985) 1034-1036
11. Judd L.L., Akiskal H.S., Schettler P.J., Endicott J., Maser J., Solomon D.A., et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry 59 (2002) 530-537
12. Judd L.L., Akiskal H.S., Schettler P.J., Coryell W., Endicott J., Maser J.D., et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Archives of General Psychiatry 60 (2003) 261-269
13. Kanba S., Yagi G., Kamijima K., Suzuki T., Tajima O., Otaki J., et al. The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania. Progress in Neuropsychopharmacology & Biological Psychiatry 18 (1994) 707-715
14. Keck Jr. P.E., Calabrese J.R., McQuade R.D., Carson W.H., Carlson B.X., Rollin L.M., et al. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. Journal of Clinical Psychiatry 67 (2006) 626-637
15. Kenchaiah S., Evans J.C., Levy D., Wilson P.W., Benjamin E.J., Larson M.G., et al. Obesity and the risk of heart failure. New England Journal of Medicine 347 (2002) 305-313
16. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., and Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62 (2005) 593-602
17. Ketter T.A., Kalali A.H., and Weisler R.H. A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes. Journal of Clinical Psychiatry 65 (2004) 668-673
18. Manson J.E., Colditz G.A., Stampfer M.J., Willett W.C., Rosner B., Monson R.R., et al. A prospective study of obesity and risk of coronary heart disease in women. New England Journal of Medicine 322 (1990) 882-889
19. Masand P.S. Weight gain associated with psychotropic drugs. Expert Opinion on Pharmacotheraphy 1 (2000) 377-389
20. Masuda Y., and Karasawa T. Inhibitory effect of zonisamide on human carbonic anhydrase in vitro. Arzneimittelforschung 43 (1993) 416-418
21. McElroy S.L., Frye M.A., Suppes T., Dhavale D., Keck Jr. P.E., Leverich G.S., et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. Journal of Clinical Psychiatry 63 (2002) 207-213
22. McElroy S.L., Suppes T., Keck Jr. P.E., Black D., Frye M.A., Altshuler L.L., et al. Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. Journal of Clinical Psychiatry 66 (2005) 617-624
23. McGill Jr. H.C., McMahan C.A., Herderick E.E., Zieske A.W., Malcom G.T., Tracy R.E., et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 105 (2002) 2712-2718
24. McIntyre R.S., Konarski J.Z., Wilkins K., Soczynska J.K., and Kennedy S.H. Obesity in bipolar disorder and major depressive disorder: results from a National Community Health Survey on Mental Health and Well-Being. Canadian Journal of Psychiatry 51 (2006) 274-280
25. Mimaki T., Suzuki Y., Tagawa T., Karasawa T., and Yabuuchi H. Interaction of zonisamide with benzodiazepine and GABA receptors in rat brain. Medical Journal of Osaka University 39 (1990) 13-17
26. Naimark A., and Cherniack R.M. Compliance of the respiratory system and its components in health and obesity. Journal of Applied Physiology 15 (1960) 377-382
27. Okada M., Kawata Y., Mizuno K., Wada K., Kondo T., and Kaneko S. Interaction between Ca2+, K+, carbamazepine and zonisamide on hippocampal extracellular glutamate monitored with a microdialysis electrode. British Journal of Pharmacology 124 (1998) 1277-1285
28. Oommen K.J., and Mathews S. Zonisamide: a new antiepileptic drug. Clinical Neuropharmacology 22 (1999) 192-200
29. Ozawa K., Kobayashi K., Noda S., and Iyo M. Zonisamide-induced depression and mania in patients with epilepsy. Journal of Clinical Psychopharmacology 24 (2004) 110-111
30. Physicians' desk reference, 61st ed., Montvale, NJ: Thomson Healthcare, 2007.
31. Sachs G.S., Guille C., and McMurrich S.L. A clinical monitoring form for mood disorders. Bipolar Disorders 4 (2002) 323-327
32. Sachs G.S., Thase M.E., Otto M.W., Bauer M., Miklowitz D., Wisniewski S.R., et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biological Psychiatry 53 (2003) 1028-1042
33. Sinha R., Fisch G., Teague B., Tamborlane W.V., Banyas B., Allen K., et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. New England Journal of Medicine 346 (2002) 802-810
34. Stamler R., Stamler J., Riedlinger W.F., Algera G., and Roberts R.H. Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA 240 (1978) 1607-1610
35. Thompson D., Edelsberg J., Colditz G.A., Bird A.P., and Oster G. Lifetime health and economic consequences of obesity. Archives of Internal Medicine 159 (1999) 2177-2183
36. Waltemath C.L., and Bergman N.A. Respiratory compliance in obese patients. Anesthesiology 41 (1974) 84-85
37. Wang P.W., Sachs G.S., Zarate C.A., Marangell L.B., Calabrese J.R., Goldberg J.F., et al. Overweight and obesity in bipolar disorders. Journal of Psychiatry Research 40 (2006) 762-764